Ann: MX1 - Leadership Transition - Kingsley Hall appointed CEO, page-15

While it's getting tight money-wise (and I've belated that point a bit too much on this forum) - with the Varex milestone payments coming through in the coming quarters, the significant cost reductions and potential CE mark approval in Europe, the 8.5 M in the bank will be sufficient to see the company through to the point where Argus begins bringing in significant additional cash i.e. I don't see a capital raise anytime in the near future (obviously I could be wrong on any points I make).

It was great to hear management acknowledge the fact that Rover sales are well below where they need to be, rather than attributing it to external macro-economic factors. It should improve from here, and even if Rover sales only slightly improve going forward, it's great that we'll soon be at a stage where cash flows will be diversified across multiple product lines. With that should come a derisking of the stock in the eyes of more investors and a higher price tag to match.